Buprenorphine: revisiting the efficacy of transdermal delivery system
作者： Joseph P Kitzmiller , Christopher J Barnett , Nathan S Steiner , Nicoleta Stoicea , Nawal Kamar
DOI: 10.4155/TDE.15.3
关键词:
摘要: Introduction: Buprenorphine is a lipid-soluble pharmaceutic used in the management of chronic pain. It partial agonist at μ-opioid receptors, an antagonist κ-opioid δ-opioid receptors and ORL-1 (nociceptin) receptors. Methods: An extensive literature search, including Google Scholar Pubmed database, was conducted. Terms associated to ‘efficacy transdermal buprenorphine’ were utilized procure contemporary research articles order evaluate compare buprenorphine patch commonly traditional pain medications. Results: Transdermal has demonstrated better efficacy than conventional pharmacotherapies. Side effects similar those with other opioids included headache, dizziness, somnolence, constipation, dry mouth, nausea, vomiting, pruritus erythema. Similar delivery systems medication, buprenorphi...
future-science.com
sci-hub.se 参考文章(15)
Paola Sacerdote, Opioid-induced immunosuppression. Current Opinion in Supportive and Palliative Care. ,vol. 2, pp. 14- 18 ,(2008) , 10.1097/SPC.0B013E3282F5272E
Maria Caterina Pace, Maria Beatrice Passavanti, Elisa Grella, Luigi Mazzariello, Massimo Maisto, Manlio Barbarisi, Ena Baccari, Pasquale Sansone, Caterina Aurilio, Buprenorphine in long-term control of chronic pain in cancer patients Frontiers in Bioscience. ,vol. 12, pp. 1291- 1299 ,(2007) , 10.2741/2147
Aaron Yarlas, Kate Miller, Warren Wen, Bradley Dain, Shau Yu Lynch, Joseph V. Pergolizzi, Robert B. Raffa, Steven R. Ripa, A Randomized, Placebo-Controlled Study of the Impact of the 7-Day Buprenorphine Transdermal System on Health-Related Quality of Life in Opioid-Naïve Patients With Moderate-to-Severe Chronic Low Back Pain The Journal of Pain. ,vol. 14, pp. 14- 23 ,(2013) , 10.1016/J.JPAIN.2012.09.016
Walter Gianni, Angelo Raffaele Madaio, Moira Ceci, Elena Benincasa, Gianfranco Conati, Fabrizio Franchi, Giuseppe Galetti, Antonio Nieddu, Bernardo Salani, Stefano Maria Zuccaro, Transdermal Buprenorphine for the Treatment of Chronic Noncancer Pain in the Oldest Old Journal of Pain and Symptom Management. ,vol. 41, pp. 707- 714 ,(2011) , 10.1016/J.JPAINSYMMAN.2010.06.015
Ram P. Kapil, Alessandra Cipriano, Gregory H. Michels, Peter Perrino, Sarah A. O’Keefe, Manjunath S. Shet, Salvatore V. Colucci, Robert J. Noveck, Stephen C. Harris, Effect of Ketoconazole on the Pharmacokinetic Profile of Buprenorphine following Administration of a Once-Weekly Buprenorphine Transdermal System Clinical Drug Investigation. ,vol. 32, pp. 583- 592 ,(2012) , 10.1007/BF03261913
Ram P. Kapil, Alessandra Cipriano, Kristen Friedman, Gregory Michels, Manjunath S. Shet, Salvatore V. Colucci, Glen Apseloff, Joseph Kitzmiller, Stephen C. Harris, Once-weekly transdermal buprenorphine application results in sustained and consistent steady-state plasma levels. Journal of Pain and Symptom Management. ,vol. 46, pp. 65- 75 ,(2013) , 10.1016/J.JPAINSYMMAN.2012.06.014
Deborah J. Steiner, Steve Sitar, Warren Wen, Gosford Sawyerr, Catherine Munera, Steven R. Ripa, Craig Landau, Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid-Naïve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched, Randomized, Double-Blind, Placebo-Controlled Study Journal of Pain and Symptom Management. ,vol. 42, pp. 903- 917 ,(2011) , 10.1016/J.JPAINSYMMAN.2011.04.006
Zaki Pa, Keith De, Brine Ga, Evans Cj, Carroll Fi, Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation? Journal of Pharmacology and Experimental Therapeutics. ,vol. 292, pp. 1127- 1134 ,(2000)
Lyn Margetts, Richard Sawyer, Transdermal drug delivery: principles and opioid therapy Continuing Education in Anaesthesia, Critical Care & Pain. ,vol. 7, pp. 171- 176 ,(2007) , 10.1093/BJACEACCP/MKM033
Clive Seale, National survey of end-of-life decisions made by UK medical practitioners. Palliative Medicine. ,vol. 20, pp. 3- 10 ,(2006) , 10.1191/0269216306PM1094OA